Cargando…

Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson’s disease

BACKGROUND: Haploinsufficiency in the Gaucher disease GBA gene, which encodes the lysosomal glucocerebrosidase GBA, and ageing represent major risk factors for developing Parkinson’s disease (PD). Recently, more than fifty other lysosomal storage disorder gene variants have been identified in PD, im...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huebecker, Mylene, Moloney, Elizabeth B., van der Spoel, Aarnoud C., Priestman, David A., Isacson, Ole, Hallett, Penelope J., Platt, Frances M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6842240/ https://www.ncbi.nlm.nih.gov/pubmed/31703585 http://dx.doi.org/10.1186/s13024-019-0339-z

Ejemplares similares

Correction to: Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson’s disease
por: Huebecker, Mylene, et al.
Publicado: (2020)

Glycosphingolipid levels and glucocerebrosidase activity are altered in normal aging of the mouse brain
por: Hallett, Penelope J., et al.
Publicado: (2018)

Glycosphingolipid metabolism and its role in ageing and Parkinson’s disease
por: Wallom, Kerri-Lee, et al.
Publicado: (2021)

Altered Expression of Ganglioside Metabolizing Enzymes Results in GM3 Ganglioside Accumulation in Cerebellar Cells of a Mouse Model of Juvenile Neuronal Ceroid Lipofuscinosis
por: Somogyi, Aleksandra, et al.
Publicado: (2018)

Upregulating β-hexosaminidase activity in rodents prevents α-synuclein lipid associations and protects dopaminergic neurons from α-synuclein-mediated neurotoxicity
por: Brekk, Oeystein R., et al.
Publicado: (2020)

Amyotrophic lateral sclerosis and denervation alter sphingolipids and up-regulate glucosylceramide synthase
por: Henriques, Alexandre, et al.
Publicado: (2015)

Progressive decline of glucocerebrosidase in aging and Parkinson's disease
por: Rocha, Emily M, et al.
Publicado: (2015)

Lysosomal storage disorders: The cellular impact of lysosomal dysfunction
por: Platt, Frances M., et al.
Publicado: (2012)

Fibroblasts from idiopathic Parkinson’s disease exhibit deficiency of lysosomal glucocerebrosidase activity associated with reduced levels of the trafficking receptor LIMP2
por: Thomas, Ria, et al.
Publicado: (2021)

Inhibition of β-Glucocerebrosidase Activity Preserves Motor Unit Integrity in a Mouse Model of Amyotrophic Lateral Sclerosis
por: Henriques, Alexandre, et al.
Publicado: (2017)

Lipid and immune abnormalities causing age-dependent neurodegeneration and Parkinson’s disease
por: Hallett, Penelope J., et al.
Publicado: (2019)

Acid ceramidase involved in pathogenic cascade leading to accumulation of α-synuclein in iPSC model of GBA1-associated Parkinson’s disease
por: Kumar, Manoj, et al.
Publicado: (2023)

Differential response of the liver to bile acid treatment in a mouse model of Niemann-Pick disease type C
por: Nicoli, Elena-Raluca, et al.
Publicado: (2018)

Advantages and Recent Developments of Autologous Cell Therapy for Parkinson’s Disease Patients
por: Osborn, Teresia M., et al.
Publicado: (2020)

Secondary ganglioside GM2 accumulation in mucopolysaccharidoses
por: Sandhoff, Konrad
Publicado: (2021)

Novel Results and Concepts Emerging From Lipid Cell Biology Relevant to Degenerative Brain Aging and Disease
por: Isacson, Ole, et al.
Publicado: (2019)

Mechanism of Secondary Ganglioside and Lipid Accumulation in Lysosomal Disease
por: Breiden, Bernadette, et al.
Publicado: (2020)

Cell type-specific lipid storage changes in Parkinson’s disease patient brains are recapitulated by experimental glycolipid disturbance
por: Brekk, Oeystein Roed, et al.
Publicado: (2020)

Enhanced ubiquitin-dependent degradation by Nedd4 protects against α-synuclein accumulation and toxicity in animal models of Parkinson's disease
por: Davies, Sian E., et al.
Publicado: (2014)

The expanding boundaries of sphingolipid lysosomal storage diseases; insights from Niemann–Pick disease type C
por: Platt, Frances M.
Publicado: (2023)

Ganglioside Metabolism and Parkinson's Disease
por: Forsayeth, John, et al.
Publicado: (2018)

Lipid-dependent deposition of alpha-synuclein and Tau on neuronal Secretogranin II-positive vesicular membranes with age
por: Brekk, Oeystein R., et al.
Publicado: (2018)

The sensitivity of murine spermiogenesis to miglustat is a quantitative trait: a pharmacogenetic study
por: Bone, Wilhelm, et al.
Publicado: (2007)

TLR9-mediated dendritic cell activation uncovers mammalian ganglioside species with specific ceramide backbones that activate invariant natural killer T cells
por: Paget, Christophe, et al.
Publicado: (2019)

Truncated mutants of beta-glucosidase 2 (GBA2) are localized in the mitochondrial matrix and cause mitochondrial fragmentation
por: Sultana, Saki, et al.
Publicado: (2020)

Inhibition of Lysosome Membrane Recycling Causes Accumulation of Gangliosides that Contribute to Neurodegeneration
por: Boutry, Maxime, et al.
Publicado: (2003)

An iPSC model of hereditary sensory neuropathy-1 reveals L-serine-responsive deficits in neuronal ganglioside composition and axoglial interactions
por: Clark, Alex J., et al.
Publicado: (2021)

Imaging Mass Spectrometry Technology and Application on Ganglioside Study; Visualization of Age-Dependent Accumulation of C20-Ganglioside Molecular Species in the Mouse Hippocampus
por: Sugiura, Yuki, et al.
Publicado: (2008)

GM1 ganglioside-independent intoxication by Cholera toxin
por: Cervin, Jakob, et al.
Publicado: (2018)

Mutations in B4GALNT1 (GM2 synthase) underlie a new disorder of ganglioside biosynthesis
por: Harlalka, Gaurav V., et al.
Publicado: (2013)

Response to Letter to the Editor: Secondary ganglioside G(M2) accumulation in mucopolysaccharidoses
por: Derrick-Roberts, Ainslie L.K.
Publicado: (2021)

Sphingolipids and plasma membrane hydrolases in human primary bronchial cells during differentiation and their altered patterns in cystic fibrosis
por: Loberto, Nicoletta, et al.
Publicado: (2020)

Ganglioside Biochemistry
por: Kolter, Thomas
Publicado: (2012)

Gangliosides and Neuroblastomas
por: Schengrund, Cara-Lynne
Publicado: (2020)

Ganglioside and Non-ganglioside Mediated Host Responses to the Mouse Polyomavirus
por: You, John, et al.
Publicado: (2015)

Ganglioside-magnetosome complex formation enhances uptake of gangliosides by cells
por: Guan, Feng, et al.
Publicado: (2015)

Biochemical Correction of GM2 Ganglioside Accumulation in AB-Variant GM2 Gangliosidosis
por: Deschenes, Natalie M., et al.
Publicado: (2023)

The Equilibria of Sphingolipid-Cholesterol and Sphingolipid–Sphingolipid in Monolayers at the Air–Water Interface
por: Petelska, Aneta Dorota, et al.
Publicado: (2012)

Mice Lacking Major Brain Gangliosides Develop Parkinsonism
por: Wu, Gusheng, et al.
Publicado: (2011)

The Key Role of GM1 Ganglioside in Parkinson’s Disease
por: Chowdhury, Suman, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n8ovm6umaesc4bolerd19n1hgs